# Apixaban in Subjects With Peritoneal Dialysis

> **NCT04006093** · PHASE1 · COMPLETED · sponsor: **University Hospital, Caen** · enrollment: 24 (actual)

## Conditions studied

- Chronic Renal Insufficiency
- Peritoneal Dialysis

## Interventions

- **DRUG:** Apixaban single dose 5mg

## Key facts

- **NCT ID:** NCT04006093
- **Lead sponsor:** University Hospital, Caen
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-08
- **Primary completion:** 2022-12-10
- **Final completion:** 2022-12-10
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2026-03-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04006093

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04006093, "Apixaban in Subjects With Peritoneal Dialysis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04006093. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*